Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Lifeward Ltd. (LFWD)

7.65 +0.19 (+2.55%)
At close: August 31 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for LFWD
  • Previous Close 7.46
  • Open 7.47
  • Bid 8.00 x 100
  • Ask 18.00 x 100
  • Day's Range 7.41 - 7.68
  • 52 Week Range 4.14 - 10.56
  • Volume 5,398
  • Avg. Volume 10,133
  • Market Cap (intraday) 21.665M
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) --
  • EPS (TTM) -14.66
  • Earnings Date (est.) Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 20.00

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.

golifeward.com

81

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 8/31/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LFWD
10.49%
S&P 500 (^GSPC)
12.28%

1-Year Return

LFWD
0.39%
S&P 500 (^GSPC)
18.98%

3-Year Return

LFWD
87.14%
S&P 500 (^GSPC)
70.51%

5-Year Return

LFWD
93.49%
S&P 500 (^GSPC)
69.95%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 3.92M
Earnings -10.79M
Profit Margin -275.12%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-10M
-5M
0
5M
-250.0%
-200.0%
-150.0%
-100.0%

Analyst Insights

View More

Analyst Price Targets

10.00
20.00 Average
7.65 Current
30.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 3/19/2026
Analyst HC Wainwright & Co.
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 4.5 -> 10

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    20.86M

  • Enterprise Value

    18.40M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.61

  • Price/Book (mrq)

    1.71

  • Enterprise Value/Revenue

    0.84

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -141.28%

  • Return on Assets (ttm)

    -47.26%

  • Return on Equity (ttm)

    -225.65%

  • Revenue (ttm)

    21.82M

  • Net Income Avi to Common (ttm)

    -30.83M

  • Diluted EPS (ttm)

    -14.66

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.45M

  • Total Debt/Equity (mrq)

    57.20%

  • Levered Free Cash Flow (ttm)

    -7.99M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

7.65 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: